Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-03

Clinical Trial Update: Dexamethasone for Cerebral Toxoplasmosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating dexamethasone for cerebral toxoplasmosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Universitas Padjadjaran | Conditions: Toxoplasmosis, Cerebral | Phase 2 | Status: RECRUITING